Proposal for the creation of a national strategy for precision medicine in cancer: a position statement of SEOM, SEAP and SEFH

Thumbnail
View/Open
Issue date
2017
Author
Garrido, Pilar
Aldaz, Azucena
Calleja, Miguel Ángel
Álava, Enrique de
Lamas, María Jesús
Martín, Miguel
Matias-Guiu, Xavier
Palacios, José
Vera, Ruth
Suggested citation
Garrido, Pilar; Aldaz, Azucena; Calleja, Miguel Ángel; Álava, Enrique de; Lamas, María Jesús; Martín, Miguel; ... Vera, Ruth. (2017) . Proposal for the creation of a national strategy for precision medicine in cancer: a position statement of SEOM, SEAP and SEFH. Farmacia Hospitalaria, 2017, vol. 41, núm. 61, p. 688-691. https://doi.org/10.7399/fh.10877.
Impact

Google Scholar logo  Google Scholar
Share
Export to Mendeley
Metadata
Show full item record
Abstract
Precision medicine is an emerging approach for disease treatment and prevention that takes into account individual variability in genes, environment, and lifestyle for each person. Precision medicine is transforming clinical and biomedical research, as well as health care itself from a conceptual, as well as a methodological viewpoint, providing extraordinary opportunities to improve public health and lower the costs of the healthcare system. However, the implementation of precision medicine poses ethical-legal, regulatory, organizational and knowledge-related challenges. Without a national strategy, precision medicine, which will be implemented one way or another, could take place without the appropriate planning that can guarantee technical quality, equal access of all citizens to the best practices, violating the rights of patients and professionals and jeopardizing the solvency of the healthcare system. With this paper from the Spanish Societies of Medical Oncology (SEOM), Pathology (SEAP), and Hospital Pharmacy (SEFH) we highlight the need to institute a consensual national strategy for the development of precision medicine in our country, review the national and international context, comment on the opportunities and challenges for implementing precision medicine, and outline the objectives of a national strategy on precision medicine in cancer.
URI
http://hdl.handle.net/10459.1/62322
DOI
https://doi.org/10.7399/fh.10877
Is part of
Farmacia Hospitalaria, 2017, vol. 41, núm. 61, p. 688-691
Collections

The following license files are associated with this item:

cc-by-nc-nd (c) Garrido et al., 2017
Except where otherwise noted, this item's license is described as cc-by-nc-nd (c) Garrido et al., 2017